Letter: distinct hepatitis B virus relapse rates after discontinuing tenofovir and entecavir therapy in chronic hepatitis B patients-author's reply.

Chih-Hung Chen

doi:10.1111/apt.15183

Letter: distinct hepatitis B virus relapse rates after discontinuing tenofovir and entecavir therapy in chronic hepatitis B patients-author's reply.

Chih-Hung Chen

醫學系

研究成果: 期刊稿件 › 文章 › 同行評審

原文	美式英語
頁（從 - 到）	1106-1107
期刊	Alimentary Pharmacology and Therapeutics
卷	49
發行號	8
DOIs	https://doi.org/10.1111/apt.15183
出版狀態	已出版 - 2019

UN SDG

此研究成果有助於以下永續發展目標

SDG3 健康與福祉

存取文件

10.1111/apt.15183

引用此

@article{b86ab4be955d4352b958967c06107648,

title = "Letter: distinct hepatitis B virus relapse rates after discontinuing tenofovir and entecavir therapy in chronic hepatitis B patients-author's reply.",

author = "Chih-Hung Chen",

year = "2019",

doi = "10.1111/apt.15183",

language = "American English",

volume = "49",

pages = "1106--1107",

journal = "Alimentary Pharmacology and Therapeutics",

issn = "0269-2813",

publisher = "John Wiley and Sons Inc",

number = "8",

}

TY - JOUR

T1 - Letter: distinct hepatitis B virus relapse rates after discontinuing tenofovir and entecavir therapy in chronic hepatitis B patients-author's reply.

AU - Chen, Chih-Hung

PY - 2019

Y1 - 2019

U2 - 10.1111/apt.15183

DO - 10.1111/apt.15183

M3 - Journal Article

C2 - 30920034

SN - 0269-2813

VL - 49

SP - 1106

EP - 1107

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

IS - 8

ER -